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a Department of Vascular Surgery and Kidney Transplantation, University Hospital of Strasbourg, France
b Department of Hypertension, Vascular Disease and Pharmacology, University Hospital of Strasbourg, FranceIn their paper, Gernigon et al.1 evaluated the test-retest
reliability of Global Positioning System (GPS) derived mea-
surements in patients with claudication under community
walking conditions. They showed that the reliability of
greatest walking distance and average of walking speeds are
high, despite the variability of the different measured dis-
tances between two symptom limited stops during a 1 hour
stroll. This suggests that GPS technology offers new per-
spectives in the individual evaluation of walking ability and
that it might help in objectively evaluating the severity and
the impact of claudication in a patient in his daily life.
However, we would like to make some points on the paper.
The ﬁrst point is that the methodology suffers from several
limitations. Twenty patients were included over a 30 month
period and three of themwere excluded because of someGPS
issues. Moreover, there was no standardization between the
two series of evaluations, with the second test being per-
formed within 30 days of the ﬁrst, under potentially different
environmental conditions. Total time walking duration was
sometimes longer than 1 hour and it is possible that walking
25% longer could change the results. The small sample size,
the long duration of the study, the outdoor stroll, and the lack
of standardization could have inﬂuenced biased the results.
The second point is the logistics of these measurements.
The authors mentioned that the potential advantages of
GPS technology in the setting of claudication include price
of the test and the time saving. However, the cost of the
GPS device, the time needed to equip the patient and
explain the procedures, and the time to learn how to
analyze the GPS recording were not taken into consider-
ation. The authors also described some adjunctive pro-
cedures that could help in improving GPS data
interpretation (heart rate, near infrared spectroscopy,
temperature), but it is expected that the cost of GPS devices
able to record such physiological parameters would be high.
Finally, it has already been demonstrated that exercise
therapy with hospital or community based training under theDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2015.07.009
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http://dx.doi.org/10.1016/j.ejvs.2015.08.002supervision of a physical therapist or other trained medical
personnel is superior to other forms of exercise therapy, and
that increased supervision tends to lead to a greater
improvement in walking distance.2 As a result, supervised ex-
ercise has been given a class I, level of evidence A recom-
mendation by the American College of Cardiology/American
Heart Association.3 Moreover, supervised exercise therapy is
more cost-effective.4
In any case, this paper opens the door towards remote
evaluation of multiple variables associated with physical
activity in claudicants and could help to objectively measure
the impact of a given treatment in the patient’s speciﬁc
daily life conditions. Patients merely have to remember not
to leave their smartphone at home!REFERENCES
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